Clinical Trials Details

NRG-GI008 CIRCULATE (Colon)

Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

Objective

Key eligibility: Stage III resected colon or ctDNA+ Stage II; RO resection, >12cm from anal verge; pMMR/MSS.

» Learn more about this trial

Clinical Trial Categories

• Cancers and Other Neoplasms